PROSTROLANE BLANC-B 1x2 ml – Injectable Solution for Skin Brightening and Pigmentation Correction
PROSTROLANE BLANC-B 1x2 ml is an advanced injectable peptide-based solution developed by Caregen Co., Ltd. for skin brightening, tone correction, and pigmentation reduction.
This cutting-edge formulation combines biomimetic peptides and hyaluronic acid to hydrate, rejuvenate, and visibly reduce dark spots, restoring a radiant, even, and youthful complexion.
Product Overview
Prostrolane Blanc-B is designed to act at the cellular level by regulating melanin synthesis and promoting skin renewal.
It provides a comprehensive depigmenting and brightening effect, improving both tone uniformity and luminosity.
The treatment is ideal for addressing hyperpigmentation, age spots, sun damage, and post-inflammatory discoloration, resulting in visibly healthier, balanced skin.
Composition & Technology
Active Ingredients:
Biomimetic Peptides:
Oligopeptide-68: Inhibits tyrosinase activity, reducing melanin synthesis and brightening the skin
Octapeptide-11: Enhances elasticity and promotes dermal renewal
Decapeptide-4 (Rejuline™): Stimulates fibroblast activation and collagen production for firmer texture
Nonapeptide-32: Supports regeneration and antioxidant protection
Hyaluronic Acid (0.7%): Provides deep hydration and improves skin elasticity, restoring smoothness and radiance
Technology:
Sustained-Release Peptide Delivery System:
Proprietary controlled-release technology that ensures gradual peptide diffusion, allowing long-lasting melanin control, brightening, and skin tone uniformity.
Packaging
1 x 2 ml sterile vial
Product labels
Professional user instructions
Indications & Treatment Areas
Prostrolane Blanc-B is indicated for hyperpigmentation treatment, skin tone correction, and radiance enhancement in areas showing signs of uneven tone or discoloration.
Cheeks: Reduces sun and age spots
Forehead: Brightens dull skin and minimizes pigmentation
Upper Lip & Chin: Corrects perioral pigmentation
Neck & Décolleté: Improves texture and radiance
Clinical Benefits
Reduces hyperpigmentation and uneven skin tone
Inhibits melanin synthesis for clearer, brighter skin
Improves elasticity and hydration
Promotes collagen synthesis and dermal regeneration
Provides a radiant, youthful, and uniform complexion
Treatment Protocol
Injection Depth: Mid to superficial dermis
Technique: Microinjection or mesotherapy technique (0.05–0.1 ml per point)
Recommended Sessions: 3–4 sessions every 2–3 weeks
Maintenance: Every 6 months or as clinically required
Duration of Results
Results typically appear within 2–4 weeks after treatment and last 6–9 months, depending on skin type, pigmentation level, and treatment area.
Manufacturer & Regulatory Information
Manufacturer: Caregen Co., Ltd. (South Korea)
Compliance:
• CE-marked Class III Medical Device under EU Regulation (MDR) 2017/745
• ISO 13485 certified manufacturer
• Distributed under compliance with AEMPS (Agencia Española de Medicamentos y Productos Sanitarios) in Spain and the European Union
For Professional Use Only:
As trusted distributors and providers of aesthetic medicine, Aesthisave® emphasizes that our products are strictly for professional use.
We insist that these treatments be administered only by trained and medically qualified personnel, ensuring the highest standards of safety, precision, and patient care.
